bioAffinity Technologies, Inc. (BIAF:NASDAQ) closed at $2.00 on November 16, 2026, down 9.09% on the day. The stock trades 97.5% below its 52-week high of $80.70 and 2.0% above its 52-week low of $1.96. Over the past year, it lost 90.9%. bioAffinity Technologies, Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, BIAF closed higher on 94 days (37%). Its best day was March 13, 2026 (+98.13%) and its worst was September 8, 2026 (-41.52%). The stock moved 10% or more in a single session 55 times. It opened at least 5% above the previous day's high 12 times.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.
Find more stocks like BIAF with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.